Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
Results from EMERALD trial and key findings from PI3K pathway inhibitor study presented at #SABCS21
Wednesday’s General Session featured new data about the oral SERD elacestrant and the effect of tamoxifen on uterine cancer risk.
-
McGuire Award Lecture: Moving to precision care in breast cancer
Olufunmilayo I. Olopade, MD, FAACR, recounted her lifelong journey through breast cancer genomics during the William L. McGuire Memorial Lecture on Wednesday.
-
Regulatory session covers latest breast cancer treatment approvals
A special session on Wednesday reviewed the Food and Drug Administration’s recent approval of pembrolizumab for neoadjuvant and adjuvant treatment, and abemaciclib in the adjuvant setting.
-
Clinical Science Forum to focus on breast cancer-specific use of ablation for oligometastatic disease
The forum, moderated by Steven Chmura, MD, PhD, will include two state-of-the-art presentations covering what is currently known about ablation of oligometastatic disease in breast cancer.
-
Translational Science Forum examines evolving HER2 treatment paradigm
A panel of researchers and clinicians will join moderator Matthew Ellis, MB, BChir, BSc, PhD, FRCP, to review current evidence related to treatment strategies and outcomes for HER2-positive breast cancer.
-
Scenes from the exhibit hall at SABCS 2021
Time is running out to visit the SABCS 2021 exhibit hall and explore the latest industry advancements in breast cancer prevention and care.
-
Industry events for Friday at SABCS 2021
Industry exhibitors will showcase their latest breast cancer treatments, products, and technologies during five onsite presentations scheduled tomorrow.
-
New findings from SAFIR02-BREAST and NeoTRIPaPDL1 trials presented on first day of #SABCS21
Tuesday’s General Session featured presentations on abstracts that covered topics such as the clinical utility of molecular tumor profiling and imaging mass cytometry in triple-negative breast cancer.
-
COVID-19 continues to impact breast cancer treatment, trials, and outcomes
A session on Tuesday explored how the effects of the pandemic will be felt throughout the breast cancer community for years to come.
-
Brinker Award clinical research recipient highlights key role of genetic testing in breast cancer
In recognition of her trailblazing work in clinical cancer genetics, Judy E. Garber, MD, MPH, received the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research on Tuesday.